Investopedia: Agilent Still A Name Worth Owning

Even for companies with a solid record of performance, macro and sector worries can dominate the story to a large extent. That would seem to be the case with Agilent (NYSE:A), as worries about the recovery in electronic test and measurement and the health of the life sciences market weigh down the shares of what is otherwise a very interesting and well-run company. Although Agilent may not be the best pick for investors who want to make a fast buck, investors with a long-term inclination should take a deep dive into this story.

Continue reading here:
http://stocks.investopedia.com/stock-analysis/2012/Agilent-Still-A-Name-Worth-Owning--A-DHR-WAT-ILMN0516.aspx